G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 57 filers reported holding G1 THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,099,000 | +130.9% | 156,507 | +313.3% | 0.00% | +100.0% |
| Q1 2021 | $909,000 | +62.9% | 37,869 | +21.9% | 0.00% | +100.0% |
| Q4 2020 | $558,000 | +151.4% | 31,060 | +61.3% | 0.00% | – |
| Q3 2020 | $222,000 | -39.7% | 19,260 | +26.8% | 0.00% | -100.0% |
| Q2 2020 | $368,000 | +120.4% | 15,184 | 0.0% | 0.00% | – |
| Q1 2020 | $167,000 | +6.4% | 15,184 | +84.8% | 0.00% | – |
| Q4 2018 | $157,000 | -69.9% | 8,218 | -17.6% | 0.00% | -100.0% |
| Q3 2018 | $522,000 | -75.8% | 9,975 | -79.9% | 0.00% | -75.0% |
| Q2 2018 | $2,156,000 | +17.3% | 49,604 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $1,838,000 | +121.2% | 49,604 | +16.8% | 0.00% | +200.0% |
| Q4 2017 | $831,000 | – | 42,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |